<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03431194</url>
  </required_header>
  <id_info>
    <org_study_id>BN-14716</org_study_id>
    <nct_id>NCT03431194</nct_id>
  </id_info>
  <brief_title>Midodrine is Effective in Management of Intradialytic Hypotension Among Critically-ill Patients With Acute Kidney Injury</brief_title>
  <official_title>Midodrine is Effective in Management of Intradialytic Hypotension Among Critically-ill Patients With Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New Jeddah Clinic Hospital</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized trial was to assess the efficacy of oral midodrine tablets for the
      management of intradialytic hypotension among critically ill patients with acute kidney
      injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In This open -label study, patients in ICU with acute kidney injury are randomized to either
      midodrine tablets or placebo. the number of intradialytic episodes and both systolic and
      diastolic blood pressure between both groups are compared. Mortality and adverse effects are
      monitored and compared as well.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2016</start_date>
  <completion_date type="Actual">April 6, 2017</completion_date>
  <primary_completion_date type="Actual">February 19, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of hypotensive episodes</measure>
    <time_frame>30 days from start of hemodialysis</time_frame>
    <description>Number of hypotensive episodes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean systolic blood pressure</measure>
    <time_frame>30 days from start of hemodialysis</time_frame>
    <description>compare mean systolic blood pressure between the two arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean diastolic blood pressure</measure>
    <time_frame>30 days from start of hemodialysis</time_frame>
    <description>compare mean diastolic blood pressure between the two arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality in each arm</measure>
    <time_frame>30 days from start of hemodialysis</time_frame>
    <description>Number of dead patients in each arm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>midodrine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive midodrine tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive sugary oral tablets therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midodrine</intervention_name>
    <description>oral midodrine tablets 5 mg</description>
    <arm_group_label>midodrine group</arm_group_label>
    <arm_group_label>placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICU patients

          -  acute kidney injury

          -  age above 18 years

          -  documented hypotension during dialysis

        Exclusion Criteria:

          -  packed red blood cells transfusion

          -  intravenous inotropes

          -  alteration of blood pressure medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2018</study_first_submitted>
  <study_first_submitted_qc>February 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2018</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Mahmoud Hamada imam</investigator_full_name>
    <investigator_title>Lecturer of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>midodrine</keyword>
  <keyword>intensive care unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midodrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

